Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in INDV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,557,810
-$2,321,946 QoQ
Shares Held
62,340
-61.1% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#121
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INDV Over Time

Shares Held

Position Value (USD)

Derivatives in INDV

reported options exposure · as of Jun 30, 2026
CallValue
$37,226,519
CallShares
907,300
PutValue
$9,851,303
PutShares
240,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. INDV ranks #11 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INDV

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,851,303 240,100
2026-06-30 $2,557,810 62,340
2026-06-30 $37,226,519 907,300
2026-03-31 $5,029,200 165,000
2026-03-31 $4,879,756 160,097
2026-03-31 $5,492,496 180,200